Diabetes Self-Management Blog

The Type 2 diabetes drug rosiglitazone (brand name Avandia) has had a rough history — beginning with a study three years ago that found a 43% higher risk of heart attack associated with the drug, and recently as the focus of a report by the US Senate Finance Committee that accused GlaxoSmithKline, Avandia’s manufacturer, of intimidating physicians and playing down the cardiovascular risk posed by the drug. Glaxo has long maintained that Avandia is safe and remains an important option for doctors and patients. But if a consumer advocacy group has its way, Glaxo will not get another chance to prove Avandia’s safety.

Glaxo is currently beginning a massive study of Avandia, comparing it with competitor drug pioglitazone (Actos), called TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation). According to an article from Reuters, the trial aims to study 16,000 people before the year 2015, using 137 locations in 14 countries. The trial was requested three years ago by the US Food and Drug Administration in response to the first allegations of a higher cardiovascular risk associated with Avandia. Since then, however, more evidence of Avandia’s heart risk has emerged, prompting the nonprofit group Public Citizen to call for an end to the TIDE trial, calling it “unethical” and “dangerous,” according to a post on the Los Angeles Times blog Booster Shots. In a letter to FDA Commissioner Margaret Hamburg, Public Citizen argues that TIDE will most likely not produce more reliable evidence than already exists, yet exposes thousands of people already at high risk for heart problems to a drug known to increase that risk.

This renewed controversy comes at the same time as reports that Glaxo has settled hundreds of claims alleging that Avandia caused heart attacks or other cardiovascular problems. The total settlement is said to be around $60 million, considered to be a small amount. However, an upcoming court case involving thousands of claims could result in a much greater settlement.

In a published statement, Glaxo stressed that the board overseeing TIDE “has not expressed any concerns regarding the safety of participants in the study and has recommended that the study continue without modification.” And a spokesperson for the company noted that Avandia has been shown to control blood glucose levels for up to five years.

The FDA is currently reviewing the data on Avandia, and an advisory panel is planning to meet in July to discuss the drug’s safety. It seems unlikely, however, that the FDA will stop TIDE; the agency has specifically called for more data to evaluate Avandia, which the trial aims to provide.

What do you think — is it ethical to randomly assign a drug with safety concerns to trial participants? Would you participate in the TIDE trial? Is the FDA right to want definitive evidence of Avandia’s risks, compared with Actos? How much risk should be considered acceptable in a Type 2 diabetes drug, given the alternatives available? Leave a comment below!

POST A COMMENT       
  

Comments
  1. definately that drug should be studied more. I took the drug back in about 2005. I felt terrible the intire time. My chest felt heavy and I felt as though my stomacjh had a tumor. I requested to be taken off the drug. This was during a study I was doing in Minneapolis at the Int’l Diabetes Center at Park Nicollet for ACCORD.

    I also had a friend and she was on it and while she was her ankle looked absolutely huge. She also requested that she be removed from the drug. I do not believe that is a safe drug for alot of individuals.

    It needs to be scrutinized closely

    Posted by Dale A. |
  2. I started taking Avandia when it ws first released and approved by FDA. I see my endocronologist every 3 months and he besides my A1C he does cholestrol, etc. In 2006 I had a stroke, although my A1C was uner 7.0, my cholestrol, LDL and triglycerides, my blood pressure, etc. were all within normal range. I had no other risk factors other than taking avandia!!!

    Posted by Dee |
  3. I would like to know how old Dee was when she had the stroke. Thank you, Regards

    Posted by Lorraine |
  4. I was taking Avandia and in 1992 I was told by my Doctor to stop taking Avandia when she discovered I had “HEART FAILURE”.

    Posted by Andrew Molina |
  5. I started taking Avandia in 2005 and still take it. I have had no problems.

    Posted by Shirley Taylor |

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of R.A. Rapaport Publishing, Inc., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.


Flashpoints
Uncoordinated Care (04/23/14)
Doctor Payments Revealed (04/16/14)
The Costs of Innovation (04/09/14)
Diabetes to Go (04/02/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.


Carbohydrate Restriction: An Option for Diabetes Management
Some people find that decreasing the amount of carbohydrate they eat can help with blood glucose control. Here’s what to know about this approach.

Insulin Patch Pumps: A New Tool for Type 2
Patch pumps are simpler to operate than traditional insulin pumps and may be a good option for some people with Type 2 diabetes who need insulin.

How Much Do You Know About Vitamins?
Learn what these micronutrients can and can’t do for you.

Complete table of contents
Get a FREE ISSUE
Subscription questions